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Role of OX40 Signals in Coordinating CD4 T Cell Selection, 
Migration, and Cytokine Differentiation in T Helper (Th)1 
and Th2 Cells
 
By Peter Lane
 
From the Department of Immunity and Infection, Birmingham Medical School, Birmingham
B15 2TT, United Kingdom
 
Our survival depends on our ability to clonally expand rare
 
CD4 lymphocytes and instruct them to help effector cells.
Two very different types of CD4 T cell response are re-
quired for protective immunity. Immunity to intracellular
 
infections like tuberculosis
 
 
 
is dependent on priming and
 
expanding inflammatory IFN-
 
g
 
–expressing CD4 T cells
that acquire the capability to migrate out into the tissue and
activate macrophages to kill infected cells. In contrast, im-
munity to the exotoxin produced by diphtheria requires
CD4 T cells to be primed to migrate into B follicles to fos-
ter germinal center (GC) development and the rapid pro-
duction of high-affinity neutralizing antibodies. Although
the outcomes of these two types of CD4 response are dif-
ferent, they have the same three components: (a) Identifi-
cation and expansion of antigen-specific CD4 T cells; (b)
instruction to secrete the appropriate cytokines; and (c) in-
struction to express chemokine and adhesion molecules
that guide their migration to the appropriate location.
Recent evidence has highlighted the fact that dendritic
cells (DCs) direct CD4 T cell fate during priming (1), and
this has focused attention on costimulatory interactions at
the initiation of CD4 immune responses. In addition to
their potential to costimulate CD4 cells through CD28
ligands and IL-12, DCs have recently been shown (2, 3) to
express the ligand for the CD4 activation antigen, OX40.
Both OX40 and its ligand are upregulated during CD4 T
cell priming (4), and a model that illustrates the putative
costimulatory events is shown in Fig. 1.
 
Role of OX40 and CD28 in Priming CD4 Cells: Rapid Ex-
 
pansion in the T Zone.
 
The CD28 ligand, CD86, is consti-
tutively expressed on mature DCs, so all antigen-specific
CD4 T cells receive an initial CD28 signal. In contrast, ex-
pression of the T cell activation antigen OX40 on naive
CD4 T cells is largely CD28 dependent, both in vivo
 
 
 
and
in vitro
 
 
 
(5). Although others have suggested that OX40 ex-
pression is CD28 independent (6), these studies looked at
total rather than naive CD4 T cell responses. This is criti-
cal, as activated T cells appear to secrete cytokines that can
both promote the survival of naive CD4 T cells and upreg-
ulate OX40 (unpublished observations).
After activation, CD4 T cells reciprocally activate DCs
through CD40. In vitro, CD40 ligand (CD40L) upregulates
the expression of IL-12 in cultured DCs (7), but this may not
happen in vivo
 
 
 
for the following reason: CD4-dependent
recognition of foreign proteins presented by DCs evokes a
primary CD4 T cell cytokine response that is almost exclu-
sively IL-4 and is associated with the production of IgG1
(Th2)- but not IgG2a (Th1)-specific antibodies (1). If IL-12
is produced by CD40L-activated DCs during responses to
protein antigens, it is not sufficient to bias the CD4 response
to Th1 cytokines and IgG2a antibody production. This con-
trasts with bacterial antigens that activate DCs to express IL-
 
12 expression in vivo, evoke CD4 Th1 IFN-
 
g
 
 expression,
and switch B cells to make IgG2a antibodies.
CD40-activated but not freshly isolated DCs do express
the TNF family member OX40L in mice (3) and humans
(2), and mRNA for OX40L and OX40 is upregulated in
lymph nodes around the time of CD4 priming (4). In hu-
man tonsil, OX40 protein is most strongly expressed on
CD4 T cell blasts in the T zone (8), which is compatible
with activated CD4 T cells receiving OX40 signals when
they are primed on DCs.
This suggests a sequential model of naive CD4 T cell ac-
tivation with OX40 expression being dependent on an ini-
tial CD28 signal. Subsequent activation of DCs through
CD40 by CD4 T cell CD40L in turn upregulates DC
OX40L. OX40 and CD28 signals are highly synergistic for
CD4 T cell proliferation and survival (9). In this issue, Mu-
rata et al. (10) report that OX40L-deficient mice have im-
paired CD4 T cell priming. In contrast, constitutive expres-
sion of OX40L on DCs (3) is associated with the opposite
phenotype, with increased numbers of activated/memory
CD4 T cells (6). It seems likely that during normal CD4 T
cell priming, the combination of costimulation through
CD28 and OX40 is responsible for the rapid expansion of
antigen-specific CD4 blasts that is observed in the T zone,
peaking around day 7 (11, 12).
 
Role of CD28 and OX40 in Directing CD4 T Cell Migra-
tion to B Follicles.
 
After immunization with soluble protein
antigens, rapid expansion of antigen-specific cells in the T
zone is accompanied by their selective migration to B fol-
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licles, and this coincides with the in vivo
 
 
 
expression of
CXCR-5 (13). This chemokine receptor is responsible for
localizing lymphocytes in B follicles (14), where the ligand
is expressed (15). A key point concerning recall CD4 re-
sponses is that most primed CD4 cells are located in B folli-
cles and GCs by day 10. Signaling through CD28 and OX40
upregulates mRNA for CXCR-5 in vitro
 
 
 
(4), and CD28 sig-
naling is required to generate the CXCR-5 subset of mem-
ory CD4 T cells in vivo (5). The lack of CXCR-5–positive
CD4 T cells in CD28-deficient mice is directly correlated
with their failure to form GCs (16). Whereas CD28 signal-
ing is absolutely required for the generation of CD4 T cell
help for GCs, an IL-12–dependent Th1 inflammatory CD4
immune response to the intracellular pathogen 
 
Leishmania
 
is not CD28 dependent (17).
The migration of CXCR-5–positive CD4 cells into B
follicles is mediated in part by CD28-dependent OX40 sig-
nals. Constitutive expression of OX40L on DCs leads to a
CD28-dependent increase in the numbers of CXCR-5
CD4 cells (5), greatly increased numbers of CD4 T cells
within B follicles, and large GCs (3). Preliminary analysis of
 
OX40-deficient mice shows the opposite phenotype, with
GC formation being reduced (unpublished observations).
These data are consistent with two hypotheses that are not
mutually exclusive: (a) OX40 signals, because they syner-
gize with CD28 signals, are required for the optimal ex-
pansion of CD4 T cells that subsequently migrate to B fol-
licles; and (b) CD28 signaling is permissive for a second
OX40-independent costimulatory event that directs expres-
sion of CXCR-5–positive CD4 T cells to follicles (OX40-
deficient mice can make GCs).
The data on OX40L-deficient mice in this issue are con-
sistent with the latter hypothesis. Murata et al. (10) have
looked at day 9 recall CD4 responses when the majority of
primed CD4 T cells in normal mice are “helping” B cells
in GCs. The in vitro CD4 recall response from T cells primed
in OX40L-deficient mice hardly depends on the expression of
OX40L upon restimulating APCs (Murata et al., compare
Figure 6 A and Figure 6 B). In marked contrast, the CD4
memory response in OX40L-sufficient mice is highly OX40L
dependent (Murata et al., Figure 6 C). This is compatible with
OX40-dependent and -independent CD4 memory pools.
Figure 1. Schematic representation of (A) immune responses evoked by protein antigens that do not promote IL-12 in DCs and (B) immune responses
(e.g., bacteria) that do. (A) Antigen-activated CD4 T cells are initially costimulated through CD28 by CD86 expressed on DCs (1). This CD28 signal
upregulates (yellow arrow indicates intracellular signals) OX40 (red color indicates CD28 dependence). Activated CD4 T cells express CD40L (2) and
activate DCs (yellow arrow) to express OX40L (blue color indicates CD40L dependence). Synergistic costimulation through CD28 and OX40 leads to
rapid expansion of CD4 T cells on the basis of their ability to recognize antigen presented by DCs (green color). These CD4 cells upregulate expression
of the cytokine IL-4 and the chemokine CXCR-5, and CD4 T cells migrate to B follicles to foster GCs. (B) The situation is identical for inflammatory
antigens, except that CD4 T cells are signaled by IL-12 (4; black color) in addition to CD28 (1). These antigens generate CD4 cells that help both anti-
body and inflammatory responses, perhaps because IL-12 upregulates inflammatory chemokine receptors. Whether an individual CD4 T cells becomes
committed to help B cells or inflammatory responses may depend on the strength of the signal through OX40L (3). This model predicts that high-affinity
CD4 cells are selected to migrate to B follicles. If CD4 cells express inflammatory chemokines, they migrate into the bloodstream, where OX40L on vas-
cular endothelium directs their migration into tissue (3). 
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The accompanying paper on OX40 in this issue by Akiba
et al. (18) also raises some interesting points in this regard.
OX40 blockade promoted rather than inhibited an inflam-
matory CD4 response to the intracellular pathogen, 
 
Leish-
mania
 
. In contrast, there was a selective deficit in Th2 B
cell help for IgG1- and IgE-specific antibody production to
 
Leishmania
 
 antigens, suggesting that CD4 B cell help was
OX40L dependent.
 
CD28-dependent OX40 Signaling of CD4 Cells during DC
Priming Biases Cytokine Production to Th2 but Promotes Migra-
tion of Both Th1 and Th2 Cells to B Follicles.
 
In vitro
 
 
 
acti-
vation of naive CD4 T cells through CD28 and OX40
promotes expression of IL-4 (4, 19). Th2 CD4 cells sup-
port GC development more effectively than Th1 CD4
cells, although Th1 and Th2 cells are effective in combina-
tion (20). This point emphasizes how OX40L signals opti-
mize B cell help. It is not clear how OX40 signals IL-4
production; it may simply cause preferential survival of cells
that have started to express IL-4.
Direct evidence that OX40 signals facilitate Th2 devel-
opment in vivo
 
 
 
is seen in the paper by Akiba et al. (18),
where OX40 blockade of 
 
Leishmania
 
-infected BALB/c
mice inhibits production of Th2-associated antibody iso-
types IgG1 and IgE and favors inflammatory CD4 Th1 re-
sponses. The generation of protective Th1 inflammatory
CD4 T cell responses in C57BL/6 mice is also independent
of OX40 signaling. This is somewhat contradicted by Mu-
rata et al. (10), who show reduced production of the Th1
cytokine, IFN-
 
g
 
, in OX40L-deficient mice. I think the
confusion arises because Murata et al. fail to distinguish
Th1 CD4 help for B cells and Th1 CD4 help for inflamma-
tory responses. The Freund’s complete adjuvant used by
Murata et al. is a potent Th1 immunogen for antibody re-
sponses. By performing CD4 recall responses 9 d after im-
munization, when most antigen-specific CD4 cells are in B
follicles, they are mostly looking at CD4 Th1 cells that have
been primed to help B cells. Just as OX40L primes the mi-
gration of Th2 CD4 cells to follicles, I think the data are
consistent with OX40L promoting Th1 B cell help. DC
subsets that differ in their IL-12 expression and their capacity
to foster Th1 antibody responses have recently been de-
scribed (21, 22). These papers suggest that Th1 and Th2
CD4 B cell help is primed by different DC subsets. How-
ever, Murata et al. (10) have not examined an inflammatory
CD4 response, so on the available data they cannot conclude
that OX40 signals promote inflammatory Th1 CD4 T cells.
 
Strong Synergy between CD28 and OX40 Signals May Be
an Effective Mechanism for Selecting High-Affinity CD4 T Cells
and Promoting Their Migration to B Follicles.
 
Unlike CD86 that
is constitutively expressed on DCs, costimulation of CD4
T cells through OX40 depends on how effectively individ-
ual CD4 T cells solicit OX40L expression on DCs. I think
it is plausible that high-affinity CD4 cells, by costimulating
DCs more effectively through CD40, receive a more po-
tent reciprocal OX40L signal than low-affinity CD4 cells.
As CD28 and OX40 signals are synergistic, this would pro-
vide a mechanism to selectively expand high-affinity CD4
cells and favor their migration to B follicles. This model of
costimulation explains experimental data that shows that
high-affinity CD4 T cells are expanded in the T zone (23)
and then selectively exported to B follicles to foster GCs (24).
Immune responses to most bacterial antigens elicit both
CD4 help for antibody responses and inflammatory CD4 T
cells. The model presented here predicts that high-affinity
CD4 T cells, by virtue of their capacity to be more strongly
signaled through OX40, are more likely to expand rapidly,
secrete IL-4, and migrate to B follicles to foster GCs than are
low-affinity CD4 cells. This argument might explain at least
some of the data linking antigen dosage in transgenic CD4 T
cells with differences in Th1 and Th2 commitment (25).
 
IL-12 Primes Inflammatory CD4 T Cells That Are Signaled
to Migrate into Tissue via OX40L Signals from Vascular Endo-
thelium.
 
The main argument presented above has been
that CD28 and OX40 signals by DCs coordinate the selec-
tion, preferential but not exclusive Th2 differentiation, and
migration of CD4 cells to B follicles to foster GC develop-
ment. How can this explain why OX40 blockade attenu-
ates inflammatory diseases like experimental allergic en-
cephalitis (EAE; reference 26) and hapten-induced colitis
(27)? The clue is that OX40L is expressed on vascular en-
dothelium (28). The critical role of IL-12 but not IFN-
 
g
 
 in
the generation of inflammatory CD4 cells has recently
been highlighted (29). Just as CD28 and OX40 program
the expression of CXCR-5 that directs primed CD4 cell
migration to B follicles, it seems likely that IL-12 induces
expression of inflammatory chemokine receptors. Nor-
mally, activated inflammatory CD4 T cells migrate via the
efferent lymphatics into the bloodstream under the influ-
ence of chemokines and adhere to blood vessels. It seems
probable that the effects of OX40 blockade in EAE (26)
and hapten-induced colitis (27) are because OX40 signals
on endothelium promote inflammatory CD4 T cell migra-
tion into tissue (27). As OX40 expression (and therefore
migration) is CD28 dependent, CD28-deficient mice are
also not susceptible to EAE, although CD4 T cells are
primed (30). This does not exclude a role for OX40 signals
by DCs in expanding inflammatory CD4 T cells in combi-
nation with IL-12. However, it is clear from the data of
Akiba et al. (18) that OX40 blockade facilitates rather than
inhibits the development of a Th1 inflammatory CD4 re-
sponse, whereas it clearly attenuates Th2 cell help for B cells.
One final point is that OX40 blockade did not prevent
CD4 T cells from controlling footpad infections with 
 
Leish-
mania
 
 in BALB/c mice. Perhaps this infection causes local
inflammation that allows OX40-independent CD4 T cell
migration into tissues.
 
New Experiments.
 
These new and interesting data on
OX40 raise several points and suggest many new avenues
of inquiry into the function of OX40. First, How does
OX40 regulate CD4 inflammation? The role of OX40L
expressed on vascular endothelium needs to be dissected
from expression on DCs and other cells. This could be ad-
dressed using chimeric mice in which the bone marrow–
derived cells are OX40L sufficient (normal) but the endo-
thelial cells are OX40L deficient. The reverse experiment
would test whether OX40L-deficient DCs could prime an 
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inflammatory CD4 T cell response if OX40L was expressed
on endothelium. These experiments would address whether
OX40L plays a significant role in the priming of inflamma-
tory CD4 T cells as distinct for modifying migration of in-
flammatory CD4 cells into tissues. 
Second, Are there OX40-dependent and independent
CD4 memory subsets? The experimental data of Murata
et al. (10) indicate that this might be so. If confirmed, it
would be very interesting to define the cytokines and
chemokine receptors expressed by these CD4 T cell subsets.
Third, the synergy between OX40 and CD28 provides a
potential mechanism for selecting CD4 T cells on the basis
of their affinity. The CD4 T cell response to pigeon cyto-
chrome C model is well characterized and would provide
an excellent system in which to test this possible mecha-
nism (11, 23). It would be very interesting to establish
whether the impaired CD4 T cell memory reported here
in OX40L-deficient mice was linked with a failure to effi-
ciently expand high-affinity CD4 T cells and export them
to B follicles.
 
Conclusions.
 
In this commentary, I have cited evidence
that CD28-dependent OX40 signals from DCs coordinate
the selection, migration, and cytokine differentiation of both
Th1 and Th2 CD4 T cell help for B cell GCs. Although
OX40L signals bias cytokine production to Th2, this does
not exclude OX40L, in combination with IL-12 priming,
Th1 B cell help. I think the preferential involvement of these
costimulatory molecules in the GC pathway is because there
has been strong selection for rapid onset neutralizing anti-
body responses that are GC dependent. High-affinity CD4
cells by virtue of their capacity to activate and select B cell
somatic variants are well suited to this role. Evidence for the
priming of CD4 inflammatory cells by OX40 signals is less
convincing. The role of OX40 signals in inflammatory CD4
responses may be restricted to directing their migration from
vascular endothelium into tissues.
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